Share Price Performance Share price performance can be measured using the movement in the Argo share price (ASX code: ARG) assuming that dividends paid are reinvested. The figures below are compound annual growth rates and are compared with the S&P/ASX 200 Accumulation Index for various periods.
Brachytherapy may cause temporary urinary problems from swelling of the prostate after the insertion of the hollow needles when the seed implant is performed. Brachytherapy may also cause temporary bowel problems.
Common causes. Blockage (obstruction): The most common cause of blockage of the urethra in men is enlargement of the prostate. In males, the prostate gland partially surrounds the urethra. If the prostate becomes enlarged, which is common in older men, it presses on the urethra and can block it. The most common cause of prostate enlargement is benign prostatic hypertrophy (often called BPH). Other causes of prostate enlargement include prostate cancer and prostate infection (prostatitis).